Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Pharmaceutical and Device
GlaxoSmithKline (GSK) To Stop Speaker Programs, Supporting Healthcare…
Today, GlaxoSmithKline (GSK) announced that they will stop paying healthcare professionals for speaking engagements and for…
FTC Final Changes to the Premerger and Patent Transfer Notification Rules…
The Federal Trade Commission has revised the rules dictating when pharmaceutical companies must report a transfer of exclusive…
FDA: The Differences with Pharmaceutical and Device Promotion Standards
Over the years we have noted in our coverage of FDLI's Enforcement and Litigation Conference that DOJ and other officials…
PhRMA and Local Pharmacists Litigate to Stop Maine Pharmaceutical…
As reported in the Wall Street Journal and Smart Brief: "Businesses are confused as to whether to act now or wait for the U.S.…
Impacts of Pharmaceutical Marketing and Healthcare Services in the District…
In April of last year, we wrote about Washington, DC's AccessRX Act, which requires pharmaceutical companies that market…
Nearly Half of US Physicians Restrict Access by Manufacturer Sales Reps –…
With the Physician Payment Sunshine Act in full effect, the challenges that pharmaceutical sales representatives will…
The Significant Physician Contribution to the Development of Medical…
With increased calls for transparency in physician-industry relationships, including the Physician Payment Sunshine Act and…
Despite Critics Dismissal – Off Label Prescribing May Benefit…
Over the past several years, the federal government and law enforcement agencies have increasingly investigated and prosecuted…
FDA-EMA Meeting on Orphan Drug Development: Offers Overview of Program and…
The Food and Drug Administration (FDA) recently announced its Office of Orphan Products Development will be holding a meeting…
FDA: Trends in Enforcement Letters from the Office of Prescription Drug…
During the recent Food and Drug Law Institute's (FDLI) Advertising & Promotion Conference, Julie K Tibbets, a Partner at…